Barclays Maintains Overweight on Nutanix, Lowers Price Target to $71
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Tim Long maintains an Overweight rating on Nutanix but lowers the price target from $80 to $71.
August 20, 2024 | 3:37 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays analyst Tim Long maintains an Overweight rating on Nutanix but lowers the price target from $80 to $71, indicating a positive outlook but with adjusted expectations.
The Overweight rating suggests a positive outlook on Nutanix, but the lowered price target indicates adjusted expectations for its stock performance. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100